资讯

Cash and cash equivalents totaled €81.8 million as of December 31, 2024. In addition, completion in early 2025 of: (i) a non-dilutive royalty financing agreement for up to €185 million including a fir ...
In 2024, Iqirvo® received marketing approval in PBC in both the United States and Europe, and was subsequently commercially launched in the U.S. and in some European countries by Ipsen, who reported ...